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This study evaluated the surgical outcome and
complications of phacoemulsification and the implantation
of an acryl foldable intraocular lens (IOL) with a squared
edge in dogs with cataracts. Thirty-two eyes from 26 dogs
were examined. The mean follow up period was 75.9 days
ranging from 23 to 226 days. The complications after
phacoemulsification were posterior capsular opacity (PCO)
around the IOL (n = 11), ocular hypertension (n = 4),
focal posterior synechia (n = 4), hyphema (n = 3) and
corneal ulcer (n = 2). The complications associated with
the IOL were decenteration of the optic (n = 2) and
ventral haptic displacement (n = 1). Most cases of PCO
were found only around the margin of the IOL, and all
eyes had vision during the observation period. In
conclusion, the implantation of an acryl-foldable lens with
a squared edge at the time of phacoemulsification is an
effective method for preserving the central visual field of
dogs with cataract.
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Introduction
Cataract extraction is a type of ophthalmic surgery frequently
performed in veterinary medicine. Various surgical techniques
have been used but phacoemulsification with the implantation
of an intraocular lens (IOL) is currently the treatment of
choice. IOL implantation improves the optics of the aphakic
eye and reduces the formation of posterior capsular opacity
(PCO) after surgery [1,15]. However, IOL decenteration or
luxation can cause visual alterations or increase the risk of
postoperative complications [1,15]. Another potential
disadvantage of IOL implantation is transient intraocular
inflammation [11].
In order to achieve postoperative emmetropia, many
researchers have documented the diopter (D) of IOL optic in
dogs [3,17] with an IOL of approximately 40 D being mainly
used in canine cataract surgery. The most widely used IOL
material in veterinary practice is polymethylmethacrylate
(PMMA) [12]. However, the use of various IOL materials
such as silicone and hydroxyethylmethacrylate (HEMA)
optic IOL have also been examined [6,10]. Because acrylic
and silicone lenses are flexible, they can be implanted
through a small corneal incision (2.5-3.5 mm) [5]. This
small incision reduces the surgically induced astigmatism
associated the use of a PMMA optic IOL, which requires a
corneal incision large enough to accommodate an 8-9 mm
implant [5,8]. Recently, 41 D foldable IOL made from
silicone was reported in dogs [6]. However, it is a posterior
chamber type IOL, which carries a high risk of pupil
capture, chronic iridocyclitis and posterior synechia [8].
An acryl IOL with a squared edge is associated with a
lower incidence of induced PCO than other lens materials
[5,14]. This is because acryl lenses have strong adhesion to
the posterior capsule and the specific optical design (squared)
can inhibit the migration of lens epithelial cells into the optic
area [5]. Flexible acryl IOLs are commonly implanted in
dogs but the IOL optic is not specifically designed to prevent
PCO [7]. This study evaluated the surgical outcomes and
complications of phacoemulsification with the implantation
of a flexible acryl IOL in dogs with cataracts. The study also
examined the effects of the squared edge design of the IOL
on PCO formation.
Materials and Methods
The medical records of dogs undergoing phacoemulsification
with the implantation of an IOL at the Veterinary Medical
Teaching Hospital of Seoul National University between
October 2004 and January 2006 were reviewed. The
following information was analyzed: signalment (age,
gender and breed), stages of cataract, surgical outcomes and
postoperative complications.
Postoperative ocular hypertension was defined as an
intraocular pressure (IOP) >25 mmHg within 72 h after
surgery, and >30 mmHg after 72 h after surgery. Aqueous
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flare was graded on a scale of 0 to 3+ (0 = normal anterior
chamber; 1+ = mild flare; 2+ = moderate flare, the slit lamp
beam in the anterior chamber is equally opaque as the beam
passing through the normal lens; and 3+ = severe flare, the
slit beam in the anterior chamber is more opaque than that
passing through the lens) [10]. Corneal opacity was rated
from 0 to 4+ (0= normal cornea; 1+ = mild loss of transparency;
2+ = moderate loss of transparency; 3+ = severe loss of
transparency; 4+ = opaque cornea) [10]. PCO was graded
from 0 to 3+ (0 = none; 1+ = decreased transparency but the
fundic examination is unobstructed; 2+ = decreased transparency,
and the fundic examination is partially obstructed; and
3+ = decreased transparency, and the fundic examination is
completely obstructed) [18]. The complications relevant to
the implantation of the IOL were recorded.
Preoperatively, a complete ophthalmic examination including
a Schirmer tear test (STT), slit lamp biomicroscopy,
applanation tonometry, fluorescein staining test and indirect
ophthalmoscopy were performed in all dogs. Topical
corticosteroids/antibiotics (dexamethasone/neomycin/polymyxin
B) were administered if a dog had lens-induced uveitis (LIU).
Prior to surgery, electroretinography and ocular ultrasonography
were performed in all eyes to exclude retinal diseases and to
evaluate the posterior segment of the eye.
During pre-surgical preparation, all the dogs received
topical corticosteroids/antibiotics (dexamethasone/neomycin/
polymyxin B), topical non-steroidal anti-inflammatory
agents (0.03% flurbiprofen) and mydriatics (1% atropine
sulfate and 1% tropicamide). Also, systemic non-steroidal anti-
inflammatory agents (flunixin meglumine, 0.5 mg/kg, IV),
corticosterids (dexamethasone 2 mg/kg, IV) and antibiotics
(cefazoline, 30 mg/kg, IV) were administered.
General anesthesia was induced using routine procedures,
and maintained with isoflurane inhalation. One-handed
phacoemulsification with a modification of the “crater
divide and conquer” method was performed through a 3 mm
corneal incision [8,15]. The procedure used a single piece of
IOL of 40 D, which was a flexible, injectable and consisted
of an acryl polymer optic and polypropylene haptics (Tekia,
USA). The IOL optic had a square edge. The IOL optic was
folded using IOL-holding forceps and inserted into the IOL
cartridge. After filling the capsular bag and anterior chamber
with a sodium hyaluronate (Hyaltech, UK), the IOL in the
cartridge was inserted into the capsular bag with the IOL
inserter without enlarging the corneal incision (Fig. 1-a).
The corneal incision was closed with interrupted 8-0
polyglactin 910 sutures (Johnson & Johnson, Belgium).
Postoperatively, the intraocular pressure, aqueous flare,
corneal edema, fibrin formation and PCO were evaluated at
each ophthalmic examination. Where necessary, a non-
steroidal anti-inflammatory agent (0.03% flurbiprofen),
corticosteroids/antibiotics (dexamethasone/neomycin/polymyxin
B), antibiotics (0.3% ciprofloxacin) and mydriatics (1%
atropine sulfate) were administered topically to control the
intraocular inflammation and maintain mydriasis. Corticosteroids
(prednisolone 1 mg/kg) and antibiotics (amoxicillin/clavunic
acid 12.5 mg/kg) were administered orally every 12 h for 7
days. The medical treatment for dogs that developed ocular
hypertension after surgery included the administration of
mannitol (1 g/kg, IV), topical β-adrenergic receptor blocker
(0.5% timolol maleate) and carbonic anhydrase inhibitors
(2% dorzolamide hydrochloride). During the follow-up
period, the surgical outcomes were divided into four
categories according to the specific criteria reported by
Davidson  et al. [4]. The Fischer’s exact test was used to
compare the percentage of fibrin formation according to the
cataract stage. All statistical analysis was performed using
the SPSS 12.0 analysis program. A p  value < 0.05 was
considered significant.
Fig. 1. Photograph of the IOL placement and pseudophakic eye
after phacoemulsification. (a) A flexible IOL in the cartridge was
inserted into the capsular bag through a 3 mm corneal incisio n
with an IOL inserter. (b) Four weeks after surgery, a properly
positioned IOL in the capsular bag can be seen in an 8-year-old,
male Cocker spaniel. Vacuole-type posterior capsular opacity are
formed around the margin of the optic, and there is no PCO
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Results
During the observation period, the phacoemulsification
and implantation of IOLs was performed on 32 eyes in 26
dogs (6 bilateral and 20 unilateral). The age of the dogs
ranged from 9 months to 14 years, with a mean age of 5.4
years. The study consisted of 2 males, 6 castrated males, 16
females and 2 spayed females. The most prevalent breed
was the Cocker spaniel (n = 7). Other affected breeds were
the toy Poodle (n = 5), miniature Schnauzer (n = 3), Shih
Tzu (n = 3), Siberian Husky (n=2), Yorkshire terrier (n = 2),
Maltese terrier (n = 2) and mixed breed dog (n = 2). The
postoperative follow-up periods were as follows: 14-30 days
in 32 eyes, 30-60 days in 28 eyes, 60- 90 days in 18 eyes,
and >90 days in 10 eyes. The surgically removed cataracts
were immature (n = 9, 28.1%), mature (n = 18, 56.3%) and
hypermature (n = 5, 15.6%). The preoperative LIU was
detected in 11 (34.4%) eyes from 9 dogs.
After surgery, a return of vision was reported in all eyes.
The mean IOP (mmHg) decreased below the normal IOP
range one day after surgery, and returned to the normal
range within two weeks after surgery (Table 1). One day
after surgery, the mean flare grade increased but had
resolved in all eyes within 14 days (Table 1). During the two
weeks after surgery, 8 eyes showed mild fibrin formation in
the anterior chamber or surface of the IOL, and 3 eyes
showed moderate fibrin formation. Intra-cameral injections
of a tissue plasminogen activator (tPA, 25 µg) were
performed in two dogs (4 and 16 days after surgery,
respectively) with moderate fibrin formation in the anterior
chamber, which was resolved within one day after the
injection. Mild fibrin in the other cases had dissolved
spontaneously within 3 weeks. All the dogs developed 1+ to
2+ corneal edema adjacent to the corneal incision that was
caused by mechanical trauma during surgery. The corneal
edema in all eyes regressed spontaneously within one week
even though the opacity had remained around the corneal
incisions. The postoperative results were evaluated (Table
2). The rate of excellent or good postoperative outcomes
was 93.8%. The hypermature cataracts showed significantly
more fibrin formation than the other stages of cataracts (p <
0.05).
Table 3 lists the postoperative complications after surgery.
The most common complication was PCO formation around
the optic of the IOL (11 eyes). However, the central vision
still remained because no PCO was observed behind the
optic of the IOL. Most PCO was mainly noted around the
margin of the IOL (Fig. 1-b). The incidence of PCO
increased over time, and more PCO accumulated in dogs
that had already had PCO. During the 72 h postoperative
period, postoperative ocular hypertension was developed
two Cocker spaniels but was resolved after medical treatments
for glaucoma. Ocular hypertension also developed in a
Cocker spaniel and a toy Poodle at 9 and 11 days after
surgery, respectively. Focal posterior synechia was observed
in four eyes within 30 days. Mild hyphema was noted one
day after surgery in three cases. Within one day spontaneous
resorption occurred in two eyes, and irrigation and
aspiration (I/A) was performed in one eye. No dogs showed
a recurrence of hyphema during the follow-up period.
Linear shaped, superficial corneal ulcers in the center of the
cornea were found in both eyes of one dog. Complications
associated with the implantation of the IOL were optic
decenteration (n = 2) and ventral haptic displacement from
Table 1. Intraocular pressure (IOP) and flare grade of the dogs that underwent surgery according to the follow-up periods  (mean ± SD)
Periods
1 day before 
surgery <3 days 3-14 days 14-30 days 30-60 days 60-90 days >90 days
IOP (mm Hg) 16.16 ± 4.04 13.42 ± 3.16 15.21 ± 5.30 16.26 ± 5.35 16.05 ± 4.71 15.30 ± 4.42 16.13 ± 5.14
Flare grade* 00.00 ± 0.00 01.50 ± 0.79 00.21 ± 0.05 00.00 ± 0.00 00.00 ± 0.00 00.00 ± 0.00 00.00 ± 0.00
*Flare was graded on a scale of 0 to 3+ following Gilger  et al. [10].
Table 2. Postoperative results in 32 eyes according to the cataract stage during the follow-up period*
Category
† Stage of cataract
Total (n = 32)
Immature (n = 9) Mature (n = 18) Hypermature (n = 5)
Excellent 3/9 12/18 4/5 19/32
Good 4/9 6/18 1/5 11/32
Fair 2/9 0/18 0/5 2/32
Poor 0/9 0/18 0/5 0/32
*Mean: 75.9 days.
†Excellent = Clear visual axis and no intraocular lens (IOL) decenteration; Good = 1+ posterior capsular opacity (decreased transpar ency , but the
fundus was visual with no hindrance), focal posterior synechia or mild IOL decenteration; Fair = 2+ or greater posterior capsular  opacity (decreased
transparency, the fundus was partially visual or transparency was decreased or the fundus was completely not visible), multifoc al posterior synechia,
IOL haptic dislocation or iris capture; Poor = Visual loss from complications.284 Na-Young Yi et al.
the capsular bag (n = 1). There were no other complications
such as persistent uveitis, endophthalmitis or retinal detachment
during the observation period.
Discussion
The surgical outcome in this study was similar to those
reported in previous study of phacoemulsification with an
IOL [4]. Hypermature cataracts were associated with more
fibrin formation than the other cataract stages. That may be
because a hypermature cataract is the type of cataract that
most commonly increases the risk of lens-induced uveitis if
cataract extraction is performed [19]. The frequent problems
during the placement of a PMMA optic IOL are miosis,
limited diameter anterior capsulectomy and irregular margins
of the anterior capsulectomy [8]. However, a small anterior
capsulectomy was not a factor in this study because a
flexible IOL could be inserted into the capsular bag through
an IOL cartridge opening. No dog showed miosis as a result
of iris irritation during implantation. PCO was the most
common complication associated with lens extraction [15].
The residual lens epithelial cells proliferated to form a
lentoid undergoing fibrous pseudometaplasia [2,15]. PCO is
also derived from the bonding between the capsulectomy
margin and the posterior capsule [16]. Histologically, a lens
fibrous membrane was observed in the adhesion that had
formed between the capsulectomy margin and the posterior
capsule, and the adhesion caused severe wrinkling of the
posterior capsule [16]. An intraocular lens might reduce the
incidence of PCO because it prevents wrinkling of the
posterior capsule and limits the space for lens epithelial cells
to migrate by contacting the posterior capsule [15,16].
Previous studies showed that an acryl optic IOL had a
significantly lower incidence of PCO than a PMMA optic
IOL [13,14]. It may be associated with the biophysical
properties of acryl polymer to increase the contact between
the optic and posterior capsule [5,14]. The squared edge
design of the optic provides a mechanical barrier by
inhibiting the migration of lens epithelial cells to the optic,
which can preserve the central visual field [5]. In this study,
most PCO was formed around the optic, and the central
vision was preserved in all cases. It is believed that the
appearance of PCO was caused by the high level of
adhesion of the optic to the posterior capsule and the
squared edge design of the optic. Therefore, the squared
edged, acryl IOL described in this paper appears to be the
most effective IOL in preventing PCO. However, a long-
term follow-up will be needed because PCO may develop
several years after cataract surgery.
Ocular hypertension after cataract surgery may often
occur in some breeds, such as Shih Tzu, Cocker spaniel and
Boston terrier [18]. Similar to a previous study, the Cocker
spaniel was the most common breed that developed glaucoma
in this study. Transient ocular hypertension generally occurs
within 72 h in dogs that have undergone phacoemulsification
[15]. However, aphakic glaucoma can occur within one
month after surgery when the dogs have persistent anterior
uveitis or a fully dilated pupil [8]. Two dogs that developed
ocular hypertension 7 days after surgery received persistent
topical mydriatics therapy with no flare in anterior chamber
being noted in these dogs. This might be related to the
moderately to fully dilated pupil resulting from the continuous
application of mydriatics, which may cause the occlusion of
the outflow channels. The incidence of other complications
were similar to previous reports [4,18]. One dog that developed
a bilateral corneal ulcer was a brachycephalic breed and the
condition was associated with a macropalpebral fissure. It
has been reported that infrequent blinking rates, thin central
precorneal tear film and an exposed cornea may predispose
the dog to corneal ulcers after cataract surgery, particularly
in brachycephalic breeds [8]. The use of an ocular lubricant
after surgery may relieve the problems associated with
dryness in these breeds such as corneal ulcers and/or
erosion. TPA has been used to dissolve the hyphema or
fibrin, which is formed from surgery or inflammation [9,15],
and is effective in fibrinolysis in eyes with moderate fibrin
Table 3. Prevalence of postoperative complications after surgery during the various follow-up periods in 32 eyes
Complications
Follow-up period
< 3 days
(32 eyes)
3-14 days
(32 eyes)
14-30 days
(32 eyes)
30-60 days
(28 eyes)
60-90 days
(18 eyes)
> 90 days
(10 eyes)
PCO (1+)  0 (0)* 3 (9.4) 4 (12.5) 6 (18.8) 4 (22.2) 3 (42.9)
POH 2 (6.3) 2 (6.3) 0 (0) 0 (0) 0 (0) 0 (0)
Posterior synechia 0 (0) 3 (9.4) 1 (3.1) 0 (0) 0 (0) 0 (0)
Hyphema 3 (9.4) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Corneal ulcer 2 (6.3) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
IOL problems
† 2 (6.3) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
*Number of eye (percentage of eyes with the complication).
†IOL problems are included IOL decenteration and haptic displacement.
PCO (1+) = 1+ posterior capsular opacity (transparency was decreased, but the fundus was visible with no hindrance); POH = Post operative ocular
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formation. No other complications such as hyphema after
injection were encountered.
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